🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase I of Olaparib with Radiation Therapy in Patients With Inflammatory,...
Status
Completed
Location
Institut Curie
Start Date
2017-07-24
Trial ID
NCT03109080
Treatments Being Tested
This is an open-label, multicenter, phase Ib/II study of the combination of...
Status
Terminated
Location
Huntsman Cancer Institute at the University of Utah
Start Date
2022-09-23
Trial ID
NCT05405309
Diarrhea-predominant irritable boewl syndrome(IBS-D) seriously affect the q...
Status
Unknown
Location
Xiyuanhospital
Start Date
2019-04-01
Trial ID
NCT04312477
Treatments Being Tested
A number of studies suggest that the combination of PARP inhibitors and ant...
Status
Completed
Location
Sun Yat-sen University Cancer Cetntre
Start Date
2022-09-22
Trial ID
NCT05494580
Treatments Being Tested
This is an open-label, multi-center Phase II study of fluzoparib combined w...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Cetntre
Start Date
2023-10-18
Trial ID
NCT06063070
Treatments Being Tested
To compare the effect of PRU(platelet (P2Y12) reaction units)-guided treatm...
Status
Unknown
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT02762864
Treatments Being Tested
This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2016-07-11
Trial ID
NCT02655016
Context: Hypercoagulable state associated with COVID-19 is one of the patho...
Status
Completed
Location
Faculty of Medicine
Start Date
2021-07-01
Trial ID
NCT06097429
Treatments Being Tested
Avelumab in combination with talazoparib will be investigated in patients w...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2017-10-19
Trial ID
NCT03330405
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested